| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |